Business
Madenco Biosciences Creates New Line of Cosmeceuticals to Complement Bellus Skin(TM) Serum for Anti-Aging
Madenco Biosciences Creates New Line of Cosmeceuticals to Complement Bellus Skin™ S...
About this update from Quest Pharmatech Inc.
[{"type":"text","content":"\n\n\n\nMadenco Biosciences Creates New Line of Cosmeceuticals to Complement Bellus Skin™ Serum for Anti-Aging\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nEDMONTON, May 18, 2017\n\n\n\n\n\nTSX Venture: QPT\n\n\n\nEDMONTON, May 18, 2017 /CNW/ - Madenco Biosciences Inc. (\"Madenco\"), a subsidiary of Quest PharmaTech Inc. (TSX-V: QPT) (\"Quest\"), focused on bringing clinically validated products to the consumer and dermatology market by utilizing proprietary transdermal delivery technologies, announced today that they have created the SP-DERM line of cosmeceuticals specifically targeting applications that are demanded by dermatologists and medi-spas. \n\nThe SP-DERM line is based on Madenco's proprietary SP-TechnologyTM platform that creates topically deliverable molecules with superior properties in terms of skin permeability or topical absorption. These molecules are also known as protein transduction domain (PTD) or cell-penetrating peptides/proteins (CPP). \n\nUtilizing SP-Technology TM and with guidance from Dr. Jaggi Rao MD, FRCPC, a respected Edmonton dermatologist and cosmetic surgeon, the following three products will mark the entry of the SP-DERM line: (i) SP-DERM Recovery, a post-procedural cream for promoting recovery after intensive laser treatments and/or other procedures that leave the skin barrier compromised, (ii) SP-DERM Maintenance, a maintenance cream for prolonging the effects of cosmetic procedures and (iii) SP-DERM Acne, a serum to minimize the appearance of acne scars.\n\nA preliminary pilot study in patients suffering from acne scars treated with SP-DERM Acne demonstrated improvement in both doctor assessed and self-assessed results after 4 weeks and 8 weeks of treatment with SP-DERM Acne.\n\n\"The result of this pilot study with SP-DERM Acne is encouraging and warrants further controlled clinical study\" said Dr. Jaggi Rao.  \"If proven, SP-DERM Acne could offer a unique effective therapeutic solution to millions of acne sufferers\".\n\n\"We are excited to collaborate with Dr. Rao to introduce scientifically dev...